Your prediction
Novozymes A/S B Stock
We can see a decrease in the price for Novozymes A/S B. Compared to yesterday it has lost -€0.680 (-1.190%).
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | -1.190% | 2.433% | 1.658% | -0.459% | 3.031% | 22.732% | -14.851% |
| Ems-Chemie N | 0.450% | 3.955% | 16.932% | 26.146% | 48.733% | 54.474% | 56.117% |
| Givaudan S.A. | -1.830% | 1.399% | -6.581% | -5.335% | 2.596% | 40.242% | 40.639% |
| Solvay S.A. A | -1.550% | 0.910% | 1.064% | -3.413% | -2.635% | -75.619% | -76.335% |
